CV-6209, A HIGHLY POTENT ANTAGONIST OF PLATELET-ACTIVATING-FACTOR INVITRO AND INVIVO

被引：0
|
作者：
TERASHITA, ZI
IMURA, Y
TAKATANI, M
TSUSHIMA, S
NISHIKAWA, K
机构：
[1] TAKEDA CHEM IND LTD,DIV CENT,BIOL LABS,YODOGAWA KU,OSAKA 532,JAPAN
[2] TAKEDA CHEM IND LTD,DIV CENT,CHEM LABS,YODOGAWA KU,OSAKA 532,JAPAN
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1987年 / 242卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：263 / 268
页数：6
相关论文
共 50 条
  • [31] PLATELET-ACTIVATING-FACTOR ANTAGONIST ENHANCES LUNG PRESERVATION
    CORCORAN, PC
    WANG, YN
    KATZ, NM
    STLOUIS, JD
    FOEGH, ML
    RAJAN, SS
    ANALOUEI, AR
    WALLACE, RB
    JOURNAL OF SURGICAL RESEARCH, 1992, 52 (06) : 615 - 620
  • [32] POTENT ULCEROGENIC ACTIONS OF PLATELET-ACTIVATING-FACTOR ON THE STOMACH
    ROSAM, AC
    WALLACE, JL
    WHITTLE, BJR
    NATURE, 1986, 319 (6048) : 54 - 56
  • [33] SUPPRESSION OF THE ARTHUS REACTION BY Y-24180, A POTENT AND SPECIFIC ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    OKAMOTO, H
    IWAHISA, Y
    TERASAWA, M
    AGENTS AND ACTIONS, 1992, 35 (3-4): : 149 - 158
  • [34] N-(ACYLOXYALKYL)PYRIDINIUM SALTS AS SOLUBLE PRODRUGS OF A POTENT PLATELET-ACTIVATING-FACTOR ANTAGONIST
    DAVIDSEN, SK
    SUMMERS, JB
    ALBERT, DH
    HOLMS, JH
    HEYMAN, HR
    MAGOC, TJ
    CONWAY, RG
    RHEIN, DA
    CARTER, GW
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (26) : 4423 - 4429
  • [35] MK 287 - A POTENT, SPECIFIC, AND ORALLY-ACTIVE RECEPTOR ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    HWANG, SB
    LAM, MH
    SZALKOWSKI, DM
    MACINTYRE, DE
    BACH, TJ
    LUELL, S
    MEUER, R
    SAHOO, SP
    ALBERTS, AW
    CHABALA, JC
    JOURNAL OF LIPID MEDIATORS, 1993, 7 (02): : 115 - 134
  • [36] PHARMACOLOGICAL PROPERTIES OF YM264, A POTENT AND ORALLY ACTIVE ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    YAMADA, T
    TOMIOKA, K
    SAITO, M
    HORIE, M
    MASE, T
    HARA, H
    NAGAOKA, H
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1990, 308 : 123 - 136
  • [37] BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITIES OF SR-27417, A HIGHLY POTENT, LONG-ACTING PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST
    HERBERT, JM
    BERNAT, A
    VALETTE, G
    GIGO, V
    LALE, A
    LAPLACE, MC
    LESPY, L
    SAVI, P
    MAFFRAND, JP
    LEFUR, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 259 (01): : 44 - 51
  • [38] PLATELET-ACTIVATING-FACTOR CONTRACTS HUMAN MYOMETRIUM INVITRO
    TETTA, C
    MONTRUCCHIO, G
    ALLOATTI, G
    ROFFINELLO, C
    EMANUELLI, G
    BENEDETTO, C
    CAMUSSI, G
    MASSOBRIO, M
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1986, 183 (03): : 376 - 381
  • [39] EFFECTS OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST, CV-3988, ON DIFFERENT SHOCK-MODELS IN THE RAT
    TOTH, PD
    MIKULASCHEK, AW
    CIRCULATORY SHOCK, 1986, 20 (03) : 193 - 203
  • [40] THE EFFECTS OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST (CV-3988) ON ENDOTOXIC AND HEMORRHAGIC-SHOCK IN DOGS
    DUNCAN, SG
    DEMETER, RJ
    TOTH, PD
    CRITICAL CARE MEDICINE, 1986, 14 (04) : 413 - 413
12345